CNR Institutional Research Information System

FEDELE, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.296
NA - Nord America 857
SA - Sud America 590
EU - Europa 438
AF - Africa 49
OC - Oceania 8
Totale 4.238
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 985
US - Stati Uniti d'America 807
CN - Cina 504
BR - Brasile 475
HK - Hong Kong 262
VN - Vietnam 244
IT - Italia 147
KR - Corea 113
NL - Olanda 100
AR - Argentina 45
IN - India 40
FI - Finlandia 39
DE - Germania 32
BD - Bangladesh 31
EC - Ecuador 26
FR - Francia 26
GB - Regno Unito 26
MX - Messico 23
CO - Colombia 17
JP - Giappone 17
ZA - Sudafrica 16
RU - Federazione Russa 15
IL - Israele 14
ID - Indonesia 13
PL - Polonia 13
TR - Turchia 12
IQ - Iraq 9
PK - Pakistan 9
CA - Canada 8
EG - Egitto 8
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 7
VE - Venezuela 7
CL - Cile 6
MA - Marocco 6
ES - Italia 5
PE - Perù 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
KE - Kenya 4
PT - Portogallo 4
SE - Svezia 4
UZ - Uzbekistan 4
BB - Barbados 3
GR - Grecia 3
NP - Nepal 3
PS - Palestinian Territory 3
AT - Austria 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
GT - Guatemala 2
IE - Irlanda 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
PA - Panama 2
PH - Filippine 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CG - Congo 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TZ - Tanzania 1
Totale 4.238
Salva come PNG Salva come JPEG
Città #
Singapore 602
Santa Clara 352
Hong Kong 262
Hefei 250
Beijing 134
Seoul 111
Ho Chi Minh City 77
Hanoi 59
San Jose 55
Naples 54
São Paulo 49
Ashburn 47
Los Angeles 45
Dallas 23
Helsinki 21
Buffalo 20
Marigliano 20
Giugliano in Campania 15
Minamishinagawa 14
Bengaluru 13
Da Nang 13
Dhaka 13
Lauterbourg 12
Belo Horizonte 11
Rio de Janeiro 11
Brasília 10
New York 10
Turku 10
Warsaw 10
Falkenstein 9
Haiphong 9
Quito 9
Frankfurt am Main 8
Guayaquil 8
Lappeenranta 8
Ribeirão Preto 8
Seattle 8
Biên Hòa 7
Düsseldorf 6
Johannesburg 6
Manaus 6
Sorocaba 6
Atlanta 5
Avellino 5
Boston 5
Campinas 5
Caxias do Sul 5
Curitiba 5
Hải Dương 5
Manchester 5
Phoenix 5
Quảng Ngãi 5
Quận Bình Thạnh 5
Afragola 4
Baghdad 4
Baku 4
Bari 4
Brooklyn 4
Buenos Aires 4
Chennai 4
Contagem 4
Dammam 4
Guarulhos 4
Istanbul 4
Montreal 4
Nha Trang 4
Ninh Bình 4
Nuremberg 4
Orem 4
Piracicaba 4
Portsmouth 4
Rome 4
Salvador 4
Stockholm 4
São Gonçalo 4
Tashkent 4
The Dalles 4
Thái Bình 4
Asunción 3
Bogotá 3
Bình Dương 3
Bắc Giang 3
Cape Town 3
Chicago 3
Feira de Santana 3
Franca 3
Islamabad 3
Jakarta 3
Jundiaí 3
Karachi 3
Lahore 3
Las Vegas 3
Lima 3
Milan 3
Montes Claros 3
Munich 3
Nairobi 3
Niterói 3
Nova Iguaçu 3
Phủ Lý 3
Totale 2.642
Salva come PNG Salva come JPEG
Nome #
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 90
PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. 84
HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. 81
Suppression of transformation by inhibition of HMGI-C protein synthesis: regulatory changes of NF-kB and AP-1 transcription factors. 75
Trabectedin modulates the senescence-associated secretory phenotype and promotes cell death in senescent tumor cells by targeting NF-?B 75
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product 74
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 71
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 66
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors 63
Optimization of Short RNA Aptamers for TNBC Cell Targeting 61
HMGA1 and HMGA protein expression in mouse speramatogenesis 60
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 57
The role of the suppressor genes and of HMGI proteins. 56
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 56
The dosage of Patz1 modulates reprogramming process 55
CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. 55
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 52
Mechanism of Action of Lactic Acid on Histones in Cancer 52
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression 51
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 50
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition 49
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression 49
Profiling cancer cells by cell-selex: Use of aptamers for discovery of actionable biomarkers and therapeutic applications thereof 48
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 46
Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities 45
AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data 45
AP-1 compositional changes in transformed thyroid cells: role of fra-1 induction and functional interaction with the HMGI-C gene product. 44
HMGA2 cooperates with either p27 deficiency or Cdk4 mutation in pituitary tumorigenesis. 44
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas 43
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 43
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 43
The POZ/BTB and AT-Hook Containing Zinc Finger 1 (PATZ1) Transcription Regulator: Physiological Functions and Disease Involvement 43
Pituitary tumors: New insights into molecular features, diagnosis and therapeutic targeting 42
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation 42
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 42
Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice 41
PATZ1 is a new prognostic marker of diffuse large B cell lymphomas 41
Transcriptional and post-transcriptional regulation of transmembrane protein 132A 40
The high mobility group A2 gene is amplified and overexpressed in human prolactinomas 39
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 39
Regulation of microRNA expression by HMGA1 proteins. 39
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype 39
Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. 39
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 39
PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context 38
POZ-, AT-hook-, and Zinc Finger-containing Protein (PATZ) Interacts with Human Oncogene B Cell Lymphoma 6 (BCL6) and Is Required for Its Negative Autoregulation 38
Role of Diet in Stem and Cancer Stem Cells 37
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 37
Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 gene. 37
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 37
Binding to the Other Side: The AT-Hook DNA-Binding Domain Allows Nuclear Factors to Exploit the DNA Minor Groove 36
Epithelial–Mesenchymal Transition (EMT) 2021 36
Overexpression of the HMGA2 gene induces mixed growth hormone cell/prolactin cell pituitary adenomas by impairment of the RB/E2F pathway 35
HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents 35
Epithelial–Mesenchymal Transition (EMT) 34
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype 34
Loss of one or two PATZ1 alleles has a critical role in the progression of thyroid carcinomas induced by the RET/PTC1 oncogene 34
PATZ1 is a target of miR-29b that is induced by Ha-Ras oncogene in rat thyroid cells 34
Animal Models of Human Pathology 2020 34
HMGA2 cooperates with either p27kip1 deficiency or Cdk4R24C mutation in pituitary tumorigenesis Cell Cycle 34
CBX7 is a tumor suppressor in mice and humans 33
PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. 32
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 32
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications 31
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ 30
Animal models of human pathology 30
Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells 30
Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRbeta aptamer 30
The Genetics of Pituitary Adenomas 26
Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. 26
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 25
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 25
Pituitary adenoma: Role of HMGA proteins 24
Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis 24
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. 24
A mutated p53 gene alters thyroid cell differentiation. 23
Thyroid differentiation is blocked by a mutated p53 gene. 23
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. 23
La trasformazione neoplastica di cellule tiroidee di ratto è associata a cambiamenti nell'attività del complesso trascrizionale AP-1. 22
Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression 22
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas 22
High-Mobility-Group protein I(Y) as potential tumour marker in Human Colorectal Carcinomas. 22
Role of HMGI-Y proteins in adipogenesis. 21
Roles of HMGA proteins in cancer. 21
The suppression of thyroid cell transformation by inhibition of HMGI-C protein synthesis is associated with changes in the AP-1 activity. 21
SOM230, a new somatostatin analog, is highly effective in the therapy of GH/PRL-secreting pituitary adenomas spontaneously developing in transgenic mice overexpressing the HMGA2 gene 21
High Mobility Group I proteins in adipocytic cell transformation. 20
A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression 20
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. 20
The HMGI-dependent increase of AP-1 activity is a necessary event for thyroid cell transformation in vivo and in vitro. 20
Animal models of human pathology 2014 20
Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas 20
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines 20
Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma 19
HAND1 gene expression is negatively regulated by the high mobility group A1 proteins and is drastically reduced in human thyroid carcinomas 19
Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein evels in sporadic breast carcinoma 19
HMGA2: A pituitary tumour subtype-specific oncogene? Mol Cell Endocrinol. 19
PATZ1 Is Overexpressed in Pediatric Glial Tumors and Correlates with Worse Event-Free Survival in High-grade Gliomas 19
High Mobility Group (HMGA1a) protein expression as a diagnostic indicator of human colorectal neoplastic diseases 19
Regulation of thymosin b10 expression by TSH and other mitogenic signals in the thyroid gland and in cultured thyrocytes 18
Totale 3.813
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.051
article - articoli 11.573
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 396
Totale 26.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202493 0 0 0 0 0 0 0 0 23 0 30 40
2024/20252.054 30 12 140 68 335 89 87 110 126 148 476 433
2025/20262.303 163 475 315 528 584 172 66 0 0 0 0 0
Totale 4.450